COMP <GO>
ECG vs AMZN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Everus Construction Group Inc. (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: ECG 5
— AMZN 3
■ METRIC PARITY
LAST: $108.06 (+2.14%) • MKT CAP: $5.52B
options-implied-move
—
LAST: $243.79 (-4.25%) • MKT CAP: $2.63T
options-implied-move
6.73%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECG VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECG | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 17.61% | +12.79 | ECG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 15.8x | -2.05 | ECG | /valuation <GO> |
| Free Cash Flow Yield | -0.21% | -1.81% | +1.60 | ECG | /fcf-yield <GO> |
| Operating Margin | 7.10% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 5.40% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 31.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.47 | 3.32 | +3.15 | ECG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.4 | 47.2 | +0.20 | ECG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 1.46 | -0.33 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 22.8x | +0.15 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.52B | $2.63T | -$2.62T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECG REV | AMZN REV | ECG GROSS % | AMZN GROSS % | ECG FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $3.75B | $0 | 12.1% | — | -$11.7M | $10.56B |
| FY 2024 | $2.85B | $0 | 11.9% | — | $35.1M | $42.95B |
| FY 2023 | $2.85B | $0 | — | — | $42.9M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECG // BETA 1.13
AMZN // BETA 1.46